News Focus
News Focus
icon url

jenna

07/22/02 11:17 AM

#6776 RE: jenna #6774

ENZN.. this is what happens to a biotech after a downgrade and this is the reason the biotechs are still some of the best shorts around. Hard to beat a biotech with no earnings, no new "miracle" drug, and a lot of empty promises for downside.